Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)
Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs) in many cases determine the effectiveness of therapy. The review discusses the reasons for low adherence to DMTs, ways to increase it. Among the most effective ways is to reduce the frequency of administratio...
Main Author: | A. N. Boyko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-08-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1851 |
Similar Items
-
Adherence to interferon β treatment in Kosovan multiple sclerosis registry
by: Blerim Myftiu, et al.
Published: (2024-01-01) -
Beliefs about Medicines and the Level of Intentional Non-Adherence to Treatment among Patients with Multiple Sclerosis Treated with First-Line Drugs
by: Aleksandra Kołtuniuk, et al.
Published: (2023-12-01) -
Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-12-01) -
Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt
by: Eman M. Khedr, et al.
Published: (2024-03-01) -
Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region
by: V. B. Laskov, et al.
Published: (2017-03-01)